Avastin
- Product NDC
- 50242-060
- 11-digit product format
- 502420060
- Labeler code
- 50242
- Product ID
- 50242-060_8debebf6-af94-4ba7-8d67-c801f4ea27eb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bevacizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Genentech, Inc.
- Application
- BLA125085
- Marketing category
- BLA
- Marketing start
- 2004-02-26
- Substance
- BEVACIZUMAB
- Active strength
- 100 mg/4mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA], Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Avastin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BEVACIZUMAB | 100 mg/4mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2S9ZZM9Q9V |
| Rxcui | 1657066, 1657068, 1657073, 1657074 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50242-060-01 | Avastin | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | | 39 |
| 50242-060-01 | Avastin | 4 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 4 | | 39 |
| 50242-060-10 | Avastin | 4 mL in 1 VIAL, SINGLE-USE | INJECTION, SOLUTION | 4 | | 39 |
| 50242-060-10 | Avastin | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | | 39 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| bevacizumab | ACTIVE INGREDIENT | 2S9ZZM9Q9V | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| bevacizumab | ACTIVE MOIETY | 2S9ZZM9Q9V | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| Sodium Phosphate, Dibasic, Anhydrous | INACTIVE INGREDIENT | 22ADO53M6F | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| Sodium Phosphate, Monobasic, Monohydrate | INACTIVE INGREDIENT | 593YOG76RN | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| Trehalose Dihydrate | INACTIVE INGREDIENT | 7YIN7J07X4 | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 21 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50242-060 | AVASTIN (BEVACIZUMAB) INJECTION, SOLUTION [GENENTECH, INC.] | 39 | Current NDC, Legacy NDC, 4 package rows | 20250108_939b5d1f-9fb2-4499-80ef-0607aa6b114e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50242-060-01 | 50242006001 | 1 VIAL, SINGLE-USE in 1 CARTON (50242-060-01) / 4 mL in 1 VIAL, SINGLE-USE | 2004-02-26 | 0000-00-00 | No | No | Current |
| 50242-060-10 | 50242006010 | 10 VIAL, SINGLE-USE in 1 CARTON (50242-060-10) > 4 mL in 1 VIAL, SINGLE-USE | 2019-04-01 | 2023-01-31 | No | No | Current |